Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BISCAR: Anaesthetic Depth and Post-Cardiac Surgery Delirium
NCT05877326Unknown
- Sponsor
- Centre Cardiologique du Nord
- Start
- Sep 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol and sevoflurane in coronary artery disease (CAD), valvular heart disease (VHD) and aortic disease (2 arms), sponsored by Centre Cardiologique du Nord. Primary endpoint: Prevalence of Delirium at Day 3. Status: unknown.
02
Drugs
propofolsevoflurane
03
Conditions
coronary artery disease (CAD)valvular heart disease (VHD)aortic disease
Beyond the preview
Go deeper on NCT05877326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05877326.